|
|
|
生技領航基金-B/累積
(美元)
| 幣別 |
淨值 |
漲跌 |
漲跌比例 |
日期 |
| 美元 |
30.88 |
-0.38 |
-1.22% |
2020/07/13 |
|
|
| 2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
| 15.99% |
8.18% |
25.28% |
62.03% |
32.92% |
3.61% |
-18.98% |
15.42% |
-17.40% |
31.81% |
| 生技領航基金-B/累積(美元)
基金資料
基金月報
|
|
● 以美國為主 - 美國生技廠商具產品及技術領先優勢且美國為全球最大藥品市場，本基金目前在美國投資比重超過九成 (2013/8月底)。
● 掌握生技技術領導產業 - 大型藥廠與生技公司間進行購併及技術合作的趨勢明確，具研發利基的公司將因而受惠。
● 兼具成長與價值的投資策略 - 採取由下而上的方式，選擇具發展潛力、技術領先且臨床數據及市場發展策略良好的個股進行投資。
● 地利之便，掌握生技產業脈動 - 富蘭克林研究團隊位居加州，緊鄰舊金山生技園區，地利之便能夠掌握生技產業最新脈動。
● 榮獲2012年及2013年Smart智富台灣基金獎(晨星技術指導)「生物科技和健康護理股票型基金獎」，2011年及2012年香港指標雜誌基金大獎「最佳生物科技行業股票基金」
● 晨星基金績效評等四顆星(2013/8月)
|
| 日期 |
淨值 |
漲跌比例 |
日期 |
淨值 |
漲跌比例 |
| 2020/07/13 |
30.88 |
-1.22% |
2020/06/29 |
30.11 |
-0.82% |
| 2020/07/10 |
31.26 |
-1.01% |
2020/06/26 |
30.36 |
-2.88% |
| 2020/07/09 |
31.58 |
-0.50% |
2020/06/25 |
31.26 |
1.43% |
| 2020/07/08 |
31.74 |
0.38% |
2020/06/24 |
30.82 |
-1.85% |
| 2020/07/07 |
31.62 |
1.57% |
2020/06/23 |
31.40 |
0.51% |
| 2020/07/06 |
31.13 |
0.58% |
2020/06/22 |
31.24 |
0.10% |
| 2020/07/03 |
30.95 |
-0.13% |
2020/06/19 |
31.21 |
3.14% |
| 2020/07/02 |
30.99 |
0.49% |
2020/06/18 |
30.26 |
0.53% |
| 2020/07/01 |
30.84 |
1.05% |
2020/06/17 |
30.10 |
0.60% |
| 2020/06/30 |
30.52 |
1.36% |
2020/06/16 |
29.92 |
1.98% |
基金績效 (可點按欄位名稱排序)
| 名稱 |
一日 |
一週 |
一個月 |
三個月 |
六個月 |
一年 |
今年以來 |
|
-1.22% |
-0.80% |
7.71% |
22.30% |
12.87% |
25.22% |
12.41% |
| NBI生技指數 |
-1.45% |
-1.55% |
7.18% |
19.83% |
15.21% |
30.07% |
13.84% |
| 費城藥物指數 |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| AMEX生技指數 |
-2.54% |
-1.81% |
5.74% |
21.35% |
12.97% |
24.23% |
13.58% |
| MSCI 全球醫療保健指數 (price) |
0.00% |
-1.51% |
3.74% |
10.39% |
1.58% |
14.80% |
2.18% |
| MSCI 製藥指數 (price) |
0.00% |
-1.78% |
2.00% |
6.27% |
-2.35% |
11.48% |
-1.74% |
| MSCI 生物科技指數 (price) |
0.00% |
-0.57% |
7.56% |
14.42% |
15.31% |
38.61% |
15.61% |
|
0.35% |
-0.96% |
4.29% |
12.41% |
5.34% |
16.76% |
5.95% |
|
0.35% |
-0.98% |
4.26% |
12.13% |
4.82% |
15.60% |
5.39% |
|
-1.27% |
0.52% |
8.81% |
17.55% |
14.14% |
31.46% |
14.41% |
|
-0.73% |
0.53% |
2.56% |
16.30% |
7.77% |
13.86% |
8.03% |
|
0.68% |
-0.58% |
3.95% |
7.57% |
1.67% |
16.33% |
3.46% |
|
1.10% |
-0.35% |
4.45% |
11.75% |
3.78% |
17.45% |
4.71% |
|
-0.35% |
-1.71% |
5.50% |
13.28% |
6.98% |
19.87% |
7.46% |
|
-0.62% |
0.28% |
2.36% |
13.86% |
7.64% |
10.18% |
8.17% |
|
-0.74% |
0.23% |
2.75% |
15.95% |
9.13% |
15.96% |
9.99% |
|
1.82% |
3.32% |
18.20% |
37.56% |
13.52% |
45.14% |
12.56% |
|
0.91% |
-1.21% |
3.02% |
6.29% |
-2.83% |
10.05% |
-1.14% |
|
-1.21% |
-0.79% |
7.81% |
22.68% |
13.59% |
26.88% |
13.21% |
|
-0.28% |
-1.35% |
2.57% |
10.78% |
-3.35% |
10.07% |
-2.61% |
|
-0.83% |
-1.97% |
5.95% |
15.33% |
4.58% |
15.79% |
4.18% |
|
-0.85% |
-2.00% |
5.87% |
15.03% |
4.06% |
14.63% |
3.60% |
|
-0.82% |
-1.98% |
5.85% |
14.99% |
3.40% |
12.77% |
2.90% |
|
-0.81% |
-1.96% |
5.91% |
15.20% |
3.80% |
13.65% |
3.32% |
|
-0.85% |
-1.96% |
6.02% |
15.55% |
4.99% |
16.67% |
4.58% |
|
-0.83% |
0.35% |
2.48% |
13.30% |
11.01% |
18.96% |
11.99% |
|
0.15% |
0.53% |
8.49% |
22.24% |
17.19% |
27.07% |
15.88% |
|
-0.27% |
0.32% |
8.10% |
18.10% |
16.03% |
29.04% |
15.80% |
|
0.16% |
0.55% |
8.60% |
22.70% |
18.45% |
30.27% |
17.20% |
|
1.08% |
0.19% |
4.30% |
14.96% |
-0.02% |
6.88% |
0.14% |
|
0.65% |
-0.01% |
3.92% |
11.05% |
-0.99% |
8.58% |
0.10% |
|
1.09% |
0.21% |
4.40% |
15.38% |
1.08% |
9.63% |
1.32% |
|
-1.05% |
0.86% |
6.67% |
27.08% |
18.37% |
33.52% |
19.03% |
|
-0.47% |
-0.58% |
0.43% |
11.76% |
0.28% |
12.62% |
1.25% |
|
-1.32% |
-1.64% |
4.90% |
12.38% |
8.51% |
23.00% |
8.71% |
|
-0.92% |
-1.14% |
5.37% |
14.59% |
5.37% |
20.67% |
5.37% |
| 基金平均績效 |
-0.19% |
-0.34% |
5.32% |
16.03% |
7.07% |
19.02% |
7.33% |
* 基金報酬率包含配息
(若未註明"*"，則基金報酬率不包含配息，對於有配息之基金，將造成總報酬率數值低估。)
本資訊僅供參考，實際數據以官方公佈資料為準。 本站自當盡力為使用者提供正確的意見及消息，但如有錯漏或疏忽，本站恕不負任何法律責任。
|
